| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | -0.029 | 0.6 |
| mRNA | JQ-1:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | 0.026 | 0.6 |
| mRNA | DMOG | GDSC1000 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | KIN001-135 | GDSC1000 | pan-cancer | AAC | 0.027 | 0.6 |